Fully Online Care
In-House Rx
Prescription IncludedYes
Telehealth IncludedYes
Online-Only OptionYes
Skip LabsNot Disclosed
- Flat-rate pricing
- No commitment required
- 100% online
- Additive-free options · Multiple pharmacy options
- Free shipping · Supplies included
- Tirzepatide, Semaglutide
- Video consultation required · Other fees may apply
- No verified LegitScript certification
- Not available in all states
Provider Plans
Monthly Plan
TirzepatideMonthly
$185/avg
PharmacyHallandale (503A)
MedRx (503A)
AdditivesNone
At Hallandale
PreservativeBenzyl Alcohol
At Hallandale
BUD (Shelf Life)90 Days
At Hallandale
BillingMonthly
CommitmentNo Commitment
Other Fees$40 Consultation
Auto-RenewsNo
| DoseYour Supply | Your Price | Your Supply | Avg/mo | Your Value |
|---|---|---|---|---|
| 2.5mg/wk10mg/mo | $185.00 | 10mg | 185 | $18.50/mg |
| 5.0mg/wk20mg/mo | $185.00 | 20mg | 185 | $9.25/mg |
| 7.5mg/wk30mg/mo | $185.00 | 30mg | 185 | $6.17/mg |
| 10.0mg/wk40mg/mo | $185.00 | 40mg | 185 | $4.63/mg |
| 12.5mg/wk50mg/mo | $185.00 | 50mg | 185 | $3.70/mg |
| 15.0mg/wk60mg/mo | $185.00 | 60mg | 185 | $3.08/mg |
| Consultation fee not included | ||||
States Excluded By Pharmacy
Hallandale (503A)AL · AR · CA · GA · HI · IN · KS · KY · MA · MI · MN · MO · MS · NC · NJ · OH · OK · PA · SC · TN · TX · VA · WI · WV
MedRx (503A)AL · AR · CA · GA · IN · KY · MI · MO · MS · NC · NJ · OH · OK · PA · SC · TN · TX · VA · WI · WV
Provider Details
Self-Pay · HSA / FSA Eligible
Credit
Insurance AcceptedNo
HSA/FSA AcceptedYes
Financing AvailableNot Disclosed
Trust
LegitScript CertifiedNot Disclosed
HIPAA CompliantYes
Free Shipping
Supplies IncludedCold-Packed
Free ShippingYes
Expedited ShippingNot Disclosed
Discreet PackagingNot Disclosed
Tirz + Sema · 503A
Format: Injection
Offers TirzepatideYes
Offers SemaglutideYes
Offers BrandNo
Other TreatmentsYes
Contact & Support
Live Chat
Phone(225) 335-8541
Address140 Del Orleans Ave., #759, Denham Springs, LA 70726
Websitehttps://www.freedomwlc.com
Provider Notes
Compliance
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.